BioVersys AG receives the 2011 Swiss Technology Award
BioVersys AG is honored with The Swiss Technology Award 2011, which is awarded since 1987 each year to Switzerland’s most innovative companies in three different categories, “Seed”, “Start-Up” and “ Maturity Stage”.
BioVersys won in the Start-Up category for its innovative technology to identify small molecules that has the potential to “switch off” antibiotic resistances in bacterial pathogens. “We are very honored to win this prestigious prize. It is recognition of our technology and motivates our entire team to continue working towards overcoming the rising threat of drug resistant bacterial infections.” stated Dr. Marc Gitzinger (CEO) and Dr. Marcel Tigges (CSO).
“This award is testimony to the pioneering nature of the BioVersys technology which represents an exciting novel approach towards achieving new anti-bacterial therapies as well as the potential to rejuvenate older, proven, safe and inexpensive antibiotics. In a world saturated with expensive medicines, this pioneering work may help address the escalating costs of healthcare in antiinfectives
by making obsolete antibiotics relevant again.” said Dr. Seng Chin Mah, Chairman of the Board.
Dr. Peter Burckhardt, CEO of EVA and President of BioValley Business Angels Club BioBAC, comments: “We are proud of BioVersys. The award is an external validation of our efforts in coaching and financing of spin-offs who translate scientific results into business.”
BioVersys AG is a privately held biopharmaceuticals company. It is a spin-off company from the ETH Zurich located in Basel. The company focuses on the research and development of new drugs and compounds, which switch off drug resistance within bacterial pathogens and thus restore the efficacy of existing antibiotics. (www.bioversys.com)
Swiss Technology Award Switzerland’s leading technology award presents the most innovative companies and promotes the innovate power of Switzerland. Initiated by Nicholas Hayek and Branko Weiss the award can look back on a long tradition and track record: Since 1987 over 1900 projects applied and about 370 winners were awarded. (www.swiss-innovation.com/award)
Media contact:
Dr. Marc Gitzinger
E-mail: info@bioversys.com
Tel: +41 61 633 22 50